Enhanced endothelin-1/Rho-kinase signaling and coronarymicrovascular dysfunction in hypertensive myocardial hypertrophy

被引：0
作者：
Merkus, Daphne [1 ]
Tune, Johnathan D. [2 ]
机构：
[1] Erasmus MC, Dept Cardiol, Room Ee2355,S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands
[2] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA
来源：
CARDIOVASCULAR RESEARCH | 2017年 / 113卷 / 11期
关键词：
RHO-KINASE INHIBITOR; HEART-FAILURE; FASUDIL;
D O I：
10.1093/cvr/cvx139
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1273 / 1275
页数：3
相关论文
共 14 条
  • [1] Abdali NT, J CLIN INVEST
  • [2] Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
    Feng, Yangbo
    LoGrasso, Philip V.
    Defert, Olivier
    Li, Rongshi
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (06) : 2269 - 2300
  • [3] Double-Blind, Placebo-Controlled Clinical Trial With a Rho-Kinase Inhibitor in Pulmonary Arterial Hypertension - A Pilot Efficacy Trial -
    Fukumoto, Yoshihiro
    Yamada, Norikazu
    Matsubara, Hiromi
    Mizoguchi, Minori
    Uchino, Kazuaki
    Yao, Atsushi
    Kihara, Yasuki
    Kawano, Mitsuhiro
    Watanabe, Hiroshi
    Takeda, Yutaka
    Adachi, Takeshi
    Osanai, Shinobu
    Tanabe, Nobuhiro
    Inoue, Teruo
    Kubo, Akihiro
    Ota, Yuri
    Fukuda, Koichiro
    Nakano, Takeshi
    Shimokawa, Hiroaki
    [J]. CIRCULATION JOURNAL, 2013, 77 (10) : 2619 - 2625
  • [4] Regulation of Coronary Blood Flow
    Goodwill, Adam G.
    Dick, Gregory M.
    Kiel, Alexander M.
    Tune, Johnathan D.
    [J]. COMPREHENSIVE PHYSIOLOGY, 2017, 7 (02) : 321 - 382
  • [5] The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease
    Hartmann, Svenja
    Ridley, Anne J.
    Lutz, Susanne
    [J]. FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [6] What can we learn about treating heart failure from the heart's response to acute exercise? Focus on the coronary microcirculation
    Heinonen, Ilkka
    Sorop, Oana
    de Beer, Vincent J.
    Duncker, Dirk J.
    Merkus, Daphne
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2015, 119 (08) : 934 - 943
  • [7] Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase
    Hofni, Amal
    Messiha, Basim A. Shehata
    Mangoura, Safwat A.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 (08) : 801 - 811
  • [8] Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway
    Hunter, J. Craig
    Zeidan, Asad
    Javadov, Sabzali
    Kilic, Ana
    Rajapurohitam, Venkatesh
    Karmazyn, Morris
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 47 (06) : 810 - 818
  • [9] The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling
    Lai, Dongwu
    Gao, Jing
    Bi, Xukun
    He, Hong
    Shi, Xiaolu
    Weng, Shaoxiang
    Chen, Yu
    Yang, Ying
    Ye, Yang
    Fu, Guosheng
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2017, 95 (02): : 155 - 165
  • [10] Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina
    Otsuka, Toshiaki
    Ibuki, Chikao
    Suzuki, Jakeshi
    Ishii, Kensukelsh
    Yoshida, Hiroshi
    Kodani, Eitaro
    Kusama, Yoshiki
    Atarashi, Hirotsugu
    Kishida, Hiroshi
    Takano, Teruo
    Mizuno, Kyoichi
    [J]. CORONARY ARTERY DISEASE, 2008, 19 (02) : 105 - 110
12